S100B and Cognitive impairment: The blood-brain barrier (BBB) dysfunction may lead to the release of molecules which usually remain confined to brain tissues, one of these molecules is S100β (S100 calcium-binding protein β) that has been considered a biomarker of cognitive impairment.[32] S100β belongs to the family of calcium-binding proteins.